Product Information
CYCLOBENZAPRINE 7.5 MG TABLET is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.2600 per EA under NDC 59746073501. Its NADAC has been published 430 times since Apr 4, 2018.
Strength
7.5 mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746073501
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077563On Market Since
10/9/2017
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has been published 430 times since Apr 4, 2018, and over the history we have for it it has declined 90.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2600 per EA |
|---|---|
| All-time high | $2.9863 (Oct 10, 2018) |
| All-time low | $0.2600 (Jun 17, 2026) |
| 52-week high | $0.3669 |
| 52-week low | $0.2600 |
| Median price | $1.0662 |
| Average price | $0.9727 |
| Largest weekly change | -68.4% (Oct 19, 2022) |
| Weeks tracked | 430 |
| Tracking since | Apr 4, 2018 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 7.5 MG TABLET, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.2600 per EA (NDC 59746073501), effective Jun 24, 2026.
How has the price of CYCLOBENZAPRINE 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has declined 90.2%. It has been tracked across 430 weekly CMS publications since Apr 4, 2018.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 7.5 MG TABLET?
Since Apr 4, 2018, the NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has ranged from a low of $0.2600 (Jun 17, 2026) to a high of $2.9863 (Oct 10, 2018), with a median of $1.0662 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 7.5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CYCLOBENZAPRINE 7.5 MG TABLET, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE 7.5 MG TABLET?
CYCLOBENZAPRINE 7.5 MG TABLET (NDC 59746073501) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification